Chemoinformaics analysis of isopongaflavone/candidin
| Molecular Weight | 334.371 | nRot | 2 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 23 |
| Exact Molecular Weight | 334.121 | nRing | 4 |
| Solubility: LogS | -5.75 | nHRing | 2 |
| Solubility: LogP | 5.097 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 50.2803 |
| nHD | 0 | BPOL | 24.1337 |
| QED | 0.684 |
| Synth | 2.647 |
| Natural Product Likeliness | 1.933 |
| NR-PPAR-gamma | 0.926 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 1 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.657 |
| MDCK | 0.0000165 |
| BBB | 0.027 |
| PPB | 0.94433 |
| VDSS | 0.59 |
| FU | 0.0423412 |
| CYP1A2-inh | 0.909 |
| CYP1A2-sub | 0.767 |
| CYP2c19-inh | 0.933 |
| CYP2c19-sub | 0.181 |
| CYP2c9-inh | 0.915 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.669 |
| CYP2d6-sub | 0.737 |
| CYP3a4-inh | 0.794 |
| CYP3a4-sub | 0.259 |
| CL | 3.19 |
| T12 | 0.181 |
| hERG | 0.034 |
| Ames | 0.609 |
| ROA | 0.326 |
| SkinSen | 0.47 |
| Carcinogencity | 0.891 |
| EI | 0.085 |
| Respiratory | 0.943 |
| NR-Aromatase | 0.929 |
| Antiviral | Yes |
| Prediction | 0.833183 |